ArticleCureus2022
Evolution of Mood Symptomatology Through the COVID-19 Pandemic: Findings From the CovidSense Longitudinal Study.
Article in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Assessing the Risk of Depression Tendency in Pregnancy and Puerperium during COVID-19 Pandemic in Poland.Healthcare (Basel, Switzerland) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background The severe acute respiratory syndrome coronavirus 2 global pandemic, with its associated coronavirus disease 2019 (COVID-19) illness, has led to significant mental, physical, social, and economic hardships. Physical distancing, isolation, and fear of illness have significantly affected the mental health of people worldwide. Several studies have documented the cross-sectional elevated prevalence of mental anguish, but due to the sudden nature of the pandemic, very few longitudinal studies have been reported, especially covering the first phase of the pandemic. CovidSense, a longitudinal adaptive study, was initiated to answer some key questions: how did the pandemic and related social and economic conditions affect depression, which groups showed more vulnerability, and what protective factors emerged as the pandemic unfolded? Methodology CovidSense was deployed from April to December 2020. The adaptive design enabled adaption to fluctuating demographics/health status. Participants were regularly queried via SMS messages about their mental health, physical health, and life circumstances. The study included 1,190 participants who answered a total of 18,783 survey panels. This was a prospective longitudinal cohort study following adult participants in the general population through the COVID-19 pandemic. The participant cohort reported self-assessed measures ranging from subjective mood ratings and substance use to validated questionnaires, such as the Quick Inventory of Depressive Symptoms (QIDS) and Cognitive and Affective Mindfulness Scale-Revised (CAMS-R). Results Participants with pre-existing physical (especially pulmonary) or mental conditions had overall higher levels of depression, as measured by the QIDS and self-reported mood. Participants with pre-existing conditions also showed increased vulnerability to the stress caused by watching the news and the increase in COVID-19 cases. Younger participants (aged 18-25 years) were more affected than older groups. People with severe levels of depression had the most variation in QIDS scores, whereas individuals with none to low depressive scores had the most variability in self-reported mood fluctuations. Conclusions The effects of pandemic-related chronic stress were predominant in young adults and individuals with pre-existing mental and medical conditions regardless of whether they had acquired COVID-19 or not. These results point to the possibility of allocating preventive as well as treatment resources based on vulnerability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.